Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman
Provided By PR Newswire
Last update: Aug 20, 2025
SAN FRANCISCO, Aug. 20, 2025 /PRNewswire/ -- On August 15, 2025, shares in Soleno Therapeutics, Inc. (NASDAQ: SLNO) experienced a significant drop following the release of a highly critical report by Scorpion Capital.
Read more at prnewswire.com
